{
    "organizations": [],
    "uuid": "6b6717723cfe50ed30e9f7eca4bc0d26d09672ec",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/01/03/business-wire-simulations-plus-sets-date-for-1st-quarter-2018-earnings-release-and-conference-call.html",
    "ord_in_thread": 0,
    "title": "Simulations Plus Sets Date for 1st Quarter 2018 Earnings Release and Conference Call",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Conference Call to be on Tuesday, January 9, 2018, at 4:15 PM ET\nLANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on Form 10-Q for the first quarter of its 2018 fiscal year on Tuesday, January 9, 2018.\nThe Company will host a conference call on January 9, 2018, at 4:15 p.m. Eastern Time. All interested parties are invited to join the call by registering here . On registering, you will receive a confirmation e-mail with instructions for joining the call. Please dial in five to ten minutes prior to the scheduled start time. For listen-only mode, you may dial (562) 247-8321, and enter access code 336-145-278. A replay will be available on the Simulations Plus website following the call.\nAbout Simulations Plus, Inc.\nSimulations Plus, Inc. is a premier developer of drug discovery and development software as well as a leading provider of both preclinical and clinical pharmacometric consulting services for regulatory submissions. The company is a global leader focused on improving the ways scientists use knowledge and data to predict the properties and outcomes of pharmaceutical and biotechnology agents. Our software is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies and regulatory agencies worldwide. Our innovations in integrating new and existing science in medicinal chemistry, computational chemistry, pharmaceutical science, biology, and physiology into our software have made us the leading software provider for physiologically based pharmacokinetic modeling and simulation. For more information, visit our website at www.simulations-plus.com .\nView source version on businesswire.com : http://www.businesswire.com/news/home/20180103005414/en/\nSimulations Plus Investor Relations\nMs. Renee Bouche, 661-723-7723\nrenee@simulations-plus.com\nor\nHayden IR\nMr. Cameron Donahue, 651-653-1854\ncameron@haydenir.com\nSource: Simulations Plus, Inc.",
    "published": "2018-01-03T16:30:00.000+02:00",
    "crawled": "2018-01-03T16:28:18.018+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "conference",
        "call",
        "tuesday",
        "january",
        "pm",
        "et",
        "lancaster",
        "business",
        "wire",
        "simulation",
        "plus",
        "nasdaq",
        "slp",
        "announced",
        "today",
        "expects",
        "file",
        "quarterly",
        "report",
        "form",
        "first",
        "quarter",
        "fiscal",
        "year",
        "tuesday",
        "january",
        "company",
        "host",
        "conference",
        "call",
        "january",
        "eastern",
        "time",
        "interested",
        "party",
        "invited",
        "join",
        "call",
        "registering",
        "registering",
        "receive",
        "confirmation",
        "instruction",
        "joining",
        "call",
        "please",
        "dial",
        "five",
        "ten",
        "minute",
        "prior",
        "scheduled",
        "start",
        "time",
        "mode",
        "may",
        "dial",
        "enter",
        "access",
        "code",
        "replay",
        "available",
        "simulation",
        "plus",
        "website",
        "following",
        "call",
        "simulation",
        "plus",
        "simulation",
        "plus",
        "premier",
        "developer",
        "drug",
        "discovery",
        "development",
        "software",
        "well",
        "leading",
        "provider",
        "preclinical",
        "clinical",
        "pharmacometric",
        "consulting",
        "service",
        "regulatory",
        "submission",
        "company",
        "global",
        "leader",
        "focused",
        "improving",
        "way",
        "scientist",
        "use",
        "knowledge",
        "data",
        "predict",
        "property",
        "outcome",
        "pharmaceutical",
        "biotechnology",
        "agent",
        "software",
        "licensed",
        "used",
        "conduct",
        "drug",
        "research",
        "major",
        "pharmaceutical",
        "biotechnology",
        "company",
        "regulatory",
        "agency",
        "worldwide",
        "innovation",
        "integrating",
        "new",
        "existing",
        "science",
        "medicinal",
        "chemistry",
        "computational",
        "chemistry",
        "pharmaceutical",
        "science",
        "biology",
        "physiology",
        "software",
        "made",
        "u",
        "leading",
        "software",
        "provider",
        "physiologically",
        "based",
        "pharmacokinetic",
        "modeling",
        "simulation",
        "information",
        "visit",
        "website",
        "view",
        "source",
        "version",
        "http",
        "simulation",
        "plus",
        "investor",
        "relation",
        "renee",
        "bouche",
        "renee",
        "hayden",
        "ir",
        "cameron",
        "donahue",
        "cameron",
        "source",
        "simulation",
        "plus",
        "inc"
    ]
}